Health Care Distributors

Pomdoctor

Pomdoctor released FY2025 Semi-Annual Earnings on December 3, 2025 (EST), with actual revenue of USD 24.17 M and EPS of USD -0.2645

Pomdoctor released FY2025 Q2 earnings on December 3, 2025 (EST), actual revenue USD 12.16 M, actual EPS USD -0.1331

Pomdoctor released FY2025 Q1 earnings on December 3, 2025 (EST), with actual revenue of USD 12.01 M and EPS of USD -0.1314

POMDOCTOR LIMITED Exercised Greenshoe Option Fully, Raising Additional $23 Million

Pomdoctor released FY2024 Q4 earnings on March 31 (EST), actual revenue USD 13.18 M, actual EPS USD -0.102

Pomdoctor released FY2024 Annual Earnings on March 31 Post-Market (EST), actual revenue USD 47.58 M, actual EPS USD -0.5259

Pomdoctor released FY2023 Annual Earnings on March 31, 2025 (EST) with actual revenue of USD 42.75 M and EPS of USD -0.5384

Pomdoctor released FY2023 Q4 earnings on March 31 (EST), actual revenue USD 12.47 M, actual EPS USD -0.0975

Pomdoctor released FY2023 9 Months Earnings on March 31 (EST), actual revenue USD 30.21 M, actual EPS USD -0.5273

Pomdoctor released FY2024 Q3 earnings on March 31 (EST), actual revenue USD 13.72 M, actual EPS USD -0.1061

Pomdoctor released FY2024 9 Months Earnings on March 31, 2025 (EST), actual revenue USD 34.45 M, actual EPS USD -0.4859

Pomdoctor released FY2023 Q3 earnings on March 31, 2025 (EST), with actual revenue of USD 12.12 M and EPS of USD -0.0948

Pomdoctor released FY2022 Annual Earnings on March 13, 2025 (EST), Actual Revenue: USD 36.23 M, Actual EPS: USD -0.7645

Pomdoctor released FY2022 Q3 earnings on March 13, 2025 (EST), with actual revenue of USD 9.481 M and EPS of USD -0.1687

Pomdoctor released FY2023 Q1 earnings on March 13, 2025 (EST), actual revenue USD 9.297 M, actual EPS USD -0.2222

Pomdoctor released FY2024 Q1 earnings on March 13, 2025 (EST) with actual revenue of USD 10.4 M and EPS of USD -0.1905

Pomdoctor released FY2023 Q2 earnings on March 13, 2025 (EST), actual revenue USD 8.793 M, actual EPS USD -0.2102

Pomdoctor released FY2024 Semi-Annual earnings on March 13, 2025 (EST), with actual revenue of USD 20.73 M and actual EPS of USD -0.3797

Pomdoctor released FY2022 Q4 earnings on March 13, 2025 (EST), actual revenue USD 9.762 M, actual EPS USD -0.1737

Pomdoctor released FY2024 Q2 earnings on March 13 (EST), actual revenue USD 10.33 M, actual EPS USD -0.1892

Enveric Biosciences

Theriva Biologics

Clearmind Medicine

FGI Industries

Psyence Biomedical

Julong

Compass Pathways

CN Energy

Beyond Meat

Cue BioPharma

Cencora

Henry Schein

McKesson

Cardinal Health

Akso Health

Cosmos Health

Wellgistics Health

Agape ATP

BIMI International Medical

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Pomdoctor(POM.US)

Pomdoctor Stock Performance Chart